Regulatory aspects for Biologic Product licensing in Australia
Abstract
The TG Act defines biological as product made, from or containing, human cells or human tissues, lives animal organs, cells or tissues, and that is used to treat or prevent disease or injury, Diagnose a condition of a person and Alter the physiological processes of a person.
The Australian Regulatory Guidelines for Biologicals (ARGB) provide the keen information for manufacturers, sponsors, professionals in healthcare and also to public about the use of human cells and tissues based therapeutic goods, live animal cells, organs and tissues (1). These all products are Biologicals. This guideline is specially written for general public. If you are a sponsor or manufacture, this will:
- Explains the biological regulatory framework is applies to manufacturer’s product and their exemption conditions (1).
- Explains the Australian regulatory requirements for supplying of Biologicals
- Explains what is required for the market authorization as per TGA especially for Biologicals.
Downloads
References
https://www.tga.gov.au/excluded-goods-orders
2. TGA [Internet]. TGA; 2019 [cited 2019 Feb 11]. Available from:
https://www.tga.gov.au
3. EMEA (European Medicines Agency) [Internet]. EMEA; 2019 [cited 2019 Jan 10]. Available from:
http://www.ema.europa.eu/ema/index.jsp?curl=/pages/home/Home_Page.jsp@jsenabled=true
4. Therapeutic Goods (Things that are Biologicals) Specification 2017 (No. 1) [Internet]. TGA; 2017 [cited 2019 Jan 12]. Available from:
https://www.tga.gov.au/therapeutic-goods-determinations
5. Therapeutic Goods (Things that are not Biologicals) Determination [Internet]. TGA; 2019 [cited 2019 Jan 25]. Available from:
https://www.tga.gov.au/therapeutic-goods-determinations
6. ISO (International Organization for standardisation) [Internet]. ISO; 2019 [cited 2019 Jan 11]. Available from:
https://www.iso.org/home.html
7. Current TG Act and TG regulations [Internet]. TGA; 2019 [cited 2019 Jan 19]. Available from:
https://www.tga.gov.au/legislation-legislative-instruments
8. TGA risk management approach to the regulation of therapeutic goods [Internet]. TGA; 2011 Sept 12 [cited 2019 Jan 24]. Available from:
https://www.tga.gov.au/tgas-risk-management-approach
9. ICH (International Conference on Harmonization) [Internet]. ICH; 2019 [cited 2019 Jan 15]. Available from:
http://www.ich.org/home.html
10. Therapeutic goods act [Internet]. TGA; 1989 [cited 2019 Feb 10]. Available from:
https://www.legislation.gov.au
11. Office of the Gene Technology Regulator [Internet]. TGA; 2019 [cited 2019 Jan 25]. Available from:
http://www.ogtr.gov.au/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
